Avoid Using the Abbreviation "tPA" for Alteplase
You'll hear controversy about whether more patients should receive alteplase (Activase) for acute ischemic stroke.
New labeling suggests broadening the scope of stroke patients who should get alteplase. But this is due to new rules designed to simplify labeling...not new evidence.
Now the Am Heart and Stroke Associations are weighing in...saying yes to using alteplase in more patients...but with a few cautions.